Tag: Paratek Pharmaceuticals

The shareholders of the Boston biopharmaceutical company Paratek Pharmaceuticals have voted to accept a $462 million buyout, writes John George for the Philadelphia Business Journal…

Paratek Pharmaceuticals, which is based in Boston but has offices in King of Prussia, is turning private after being a publicly traded company for almost…

Paratek Pharmaceuticals, the Boston biotech company with operations in King of Prussia, recently saw its stock soar 23 percent to $22.85 a share following…

While Paratek Pharmaceuticals is headquartered in Boston, the company’s expansion is currently  focused on its King of Prussia office which has recently increased threefold…